Health Care & Life Sciences » Pharmaceuticals | Ophthotech Corp.

Ophthotech Corp.

Ophthotech Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 36.2 M
Public Float
 36.08 M
Ophthotech Corp.
Stock Exchange NASDAQ Stock Market
EPS
 $4.26
Market Cap
 $85.68 M
Shares Outstanding
 36.15 M
Public Float
 32.32 M

Profile

Address
One Penn Plaza
New York New York 10119
United States
Employees -
Website http://www.ophthotech.com
Updated 09/14/2018
Ophthotech Corp. is a biopharmaceutical company,which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R.

Financials

View All

David R. Guyer
Executive Chairman
Glenn P. Sblendorio
President, Chief Executive Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.